Perioperative rosuvastatin therapy increases creatine kinase and the risk of acute kidney injury in patients undergoing cardiac surgery

26 August 2022 (16:15 - 16:55)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Rohan Wijesurendra

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail

Impact of high-intensity statin therapy on glycemic control post-acute coronary syndrome using real-world data

Doctor M. Abdelghani (Doha, QA)

Abstract Slides

Presentation thumbnail

The association between long-term statin use and cataract in both primary and secondary prevention of cardiovascular disease - a nationwide, cohort study on 597,605 cataract patients

Doctor A. Halili (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

Statin use and cardiovascular outcomes after myocardial infarction: a population-based case-control study

Doctor V. Kyto (Turku, FI)

Abstract Slides

Presentation thumbnail

Use of statins in cancer patients following acute myocardial infarction and its impact on long-term clinical outcomes.

Doctor K. Stepien (Krakow, PL)

Abstract Slides

Presentation thumbnail

Drucebo effect in statin therapy: more attributable to the patient, the doctor, or the mass media?

Doctor D. Cosmi (Perugia, IT)

Abstract Slides

Access the full session

Session thumbnail

Statin therapy: clinical role and current challenges

The Event

Event poster

ESC Congress 2022

26 August 2022 16:15 CET

You may be interested in

Congress Presentation

Where are we now? Decision-making in LDL-C lowering and CV risk

Webinar

Unmet needs in lipid management: treatment goals and how to achieve them

Congress Presentation

2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources